iBio Inc.

Last updated September 27, 2026

Organization details

Legal name
iBio Inc.
Former names
iBioPharma, Inc. InB:Biotechnologies, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
June
Ticker symbol
IBIO
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001420720
EIN
26-2797813

Board of directors

Director election results

Annual meeting of October 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 6 other boards. 6 are in the same sector.

Network of iBio Inc.'s board connections Aldeyra Therapeutics Inc. Aldeyra Therapeutics I... Apnimed Inc. Apnimed Inc. Contineum Therapeutics Inc. Contineum Therapeutics... Harmony Biosciences Holdings Inc. Harmony Biosciences Ho... LENZ Therapeutics Inc. LENZ Therapeutics Inc. Schrodinger Inc. Schrodinger Inc. Evert B. Schimmelpennink Evert B. Schimmelpen... Gary Sender Gary Sender William D. Clark William D. Clark iBio Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$98,109
4 purchases by 3 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Mar 26, 2026 Banjak Marc Officer (Chief Legal Officer) Open-market purchase +12,500 $1.64 $20,500
Mar 26, 2026 Banjak Marc Officer (Chief Legal Officer) Open-market purchase +1,434 $1.76 $2,524
Mar 19, 2026 Duran Felipe Officer (Chief Financial Officer) Open-market purchase +24,835 $2.02 $50,167
Mar 19, 2026 Martin Brenner Director, Officer (See Remarks) Open-market purchase +12,336 $2.02 $24,919
Jan 10, 2025 Duran Felipe Officer (Chief Financial Officer) Open-market purchase +9,191 $2.72 $25,000
Jan 10, 2025 Martin Brenner Director, Officer (See Remarks) Open-market purchase +9,191 $2.72 $25,000
Jan 10, 2025 Banjak Marc Officer (Chief Legal Officer) Open-market purchase +9,191 $2.72 $25,000
Jan 10, 2025 David Arkowitz Director Open-market purchase +18,382 $2.72 $49,999
Jan 10, 2025 William D. Clark Director Open-market purchase +1,838 $2.72 $4,999
Jan 10, 2025 Antonio Bernardino Guimaraes Parada Director Open-market purchase +183,823 $2.72 $499,999
Jan 10, 2025 Gary Sender Director Open-market purchase +9,191 $2.72 $25,000
Nov 1, 2023 Brenner Martin Officer (See Remarks) Open-market sale −4,881 $0.27 $1,318
Oct 3, 2023 Brenner Martin Officer (See Remarks) Open-market sale −5,267 $0.30 $1,580
Oct 2, 2023 Brenner Martin Officer (See Remarks) Open-market sale −4,215 $0.31 $1,307
Aug 28, 2023 Brenner Martin Officer (See Remarks) Open-market sale −5,011 $0.31 $1,553

Organizations in the same sector, closest in location and size first.

Questions about iBio Inc.

How many directors are on iBio Inc.'s board?

iBio Inc.'s board has 8 directors: Alexandra Kropotova, Antonio Bernardino Guimaraes Parada, David Arkowitz, Elizabeth Stoner, Evert B. Schimmelpennink, Gary Sender, Martin Brenner and William D. Clark.

Are iBio Inc. insiders buying or selling shares?

Over the last 12 months, iBio Inc. insiders bought $98,109 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="ibio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.